Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy.

Lewicky, Jordan D; Martel, Alexandrine L; Fraleigh, Nya L; Picard, Emilie; Mousavifar, Leila; Nakamura, Arnaldo; Diaz-Mitoma, Francisco; Roy, René; Le, Hoang-Thanh.

Afiliação

Lewicky JD; Health Sciences North Research Institute, 56 Walford Road, Sudbury, ON P3E 2H2, Canada.
Martel AL; Health Sciences North Research Institute, 56 Walford Road, Sudbury, ON P3E 2H2, Canada.
Fraleigh NL; Health Sciences North Research Institute, 56 Walford Road, Sudbury, ON P3E 2H2, Canada.
Picard E; Health Sciences North Research Institute, 56 Walford Road, Sudbury, ON P3E 2H2, Canada.
Mousavifar L; Cancer Research Center of Lyon, 28 rue Laennec, 69008 Lyon, France.
Nakamura A; Glycosciences and Nanomaterial Laboratory, Université du Québec à Montréal, P.O. Box 8888, Succ. Centre-Ville, Montréal, QC H3C 3P8, Canada.
Diaz-Mitoma F; Armand-Frappier Santé Biotechnologie Research Centre, Institut National de la Recherche Scientifique, 531 Boulevard des Prairies, Laval, QC H7V 1B7, Canada.
Roy R; Medicinal Sciences Division, NOSM University, 935 Ramsey Lake Road, Sudbury, ON P3E 2C6, Canada.
Le HT; Glycosciences and Nanomaterial Laboratory, Université du Québec à Montréal, P.O. Box 8888, Succ. Centre-Ville, Montréal, QC H3C 3P8, Canada.